2021
DOI: 10.1007/978-3-030-77375-5_6
|View full text |Cite
|
Sign up to set email alerts
|

Astroglia Abnormalities in Post-stroke Mood Disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(11 citation statements)
references
References 150 publications
0
9
0
Order By: Relevance
“… 7 ), and proliferating astrocytes are a likely origin for this. Also epilepsy or mood disorders following stroke or TBI have been linked to astroglia abnormalities 41 , 43 , as disease progression in Alzheimer’s disease 6 or chronic pain 42 . Indeed, proliferating astrocytes have specific molecular properties, as highlighted in previous preclinical mouse models 9 , 12 , 21 and here by GAL3 expression.…”
Section: Discussionmentioning
confidence: 99%
“… 7 ), and proliferating astrocytes are a likely origin for this. Also epilepsy or mood disorders following stroke or TBI have been linked to astroglia abnormalities 41 , 43 , as disease progression in Alzheimer’s disease 6 or chronic pain 42 . Indeed, proliferating astrocytes have specific molecular properties, as highlighted in previous preclinical mouse models 9 , 12 , 21 and here by GAL3 expression.…”
Section: Discussionmentioning
confidence: 99%
“…Decreases in serotonin levels from baseline to after rehabilitation have been correlated with worsening in cognitive functions, as indicated by changes in the Rey's figure, and the Tower of London test [69]. The altered inflammatory response by astrocytes has also been proposed to explain depression and cognitive impairment after stroke [70]. It is also possible that disruption of connections in the cognitive and limbic systems [71] caused by the vascular accident could explain the relationship between post-stroke depression and cognitive impairment.…”
Section: Discussionmentioning
confidence: 99%
“…In major depressive disorder, a disease where substantial data from human post-mortem brain tissue illustrates involvement of astroglia in both disease onset and severity as well as in treatment-assisted recovery [158][159][160], astroglial atrophy has been observed without classic indications of reactivity [161,162]. Reductions in astroglial size and/or number have been noted in cortical and limbic regions in patients with mood disorders [163]. Likewise downregulation of classic astroglial functional markers have been noted in animal models of major depressive disorder, including aquaporins, connexins, glutamate transporters and glutamine synthetase [163].…”
Section: Astrocyte Heterogeneity In Disease Statesmentioning
confidence: 99%
“…Reductions in astroglial size and/or number have been noted in cortical and limbic regions in patients with mood disorders [163]. Likewise downregulation of classic astroglial functional markers have been noted in animal models of major depressive disorder, including aquaporins, connexins, glutamate transporters and glutamine synthetase [163]. Following traumatic brain injury, reductions in GAT-3 expression coincident with onset of reactive astrogliosis, disrupt cognitive function, supporting the notion that astrocyte activation interrupts functional astrocyte heterogeneity by conversion to a reactive state [118].…”
Section: Astrocyte Heterogeneity In Disease Statesmentioning
confidence: 99%